Immune deviation and cervical carcinogenesis
Evidence is emerging that a complex interplay between high-risk human papillomavirus infection, the local microenvironment and the immune system is critical for cervical carcinogenesis. To establish persistence, the virus has to evade or overcome immune control. At the transition from precancer to c...
Main Author: | Sigrun Smola |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Papillomavirus Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852119300333 |
Similar Items
-
Human papillomavirus-driven immune deviation: challenge and novel
opportunity for immunotherapy
by: Sigrun Smola, et al.
Published: (2017-06-01) -
Angiogenesis, Thrombospondin-1 and Cervical Carcinogenesis
by: Ming-Ping Wu, et al.
Published: (2005-06-01) -
Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy
by: Sigrun Smola
Published: (2017-09-01) -
Functional Role of NRF2 in Cervical Carcinogenesis.
by: Jun-Qi Ma, et al.
Published: (2015-01-01) -
Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms
by: Suellen Herbster, et al.
Published: (2021-05-01)